1-3 of 3
Jianqin Shan, Ph.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Causes of Death for Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) Treated with Imatinib.

Andrea Renata Dean, MD, Hagop M. Kantarjian, MD, Susan O'Brien, MD, Mary Beth Rios, Alfonso Quintas-Cardama, MD, Elias Jabbour, MD, Jianqin Shan, Ph.D, Jorge Cortes, MD
Journal: Blood
Blood (2009) 114 (22): 4279.
https://doi.org/10.1182/blood.V114.22.4279.4279
Published: 2009
Journal Articles

Survival Benefit with Decitabine Compared to Historical Experience with Intensive Chemotherapy in Patients with Higher Risk Myelodysplastic Syndrome (MDS).

Elias Jabbour, MD, Hagop M. Kantarjian, M.D., Jorge Cortes, M.D., William G. Wierda, M.D., Ph.D., Alessandra Ferrajoli, M.D., Stefan Faderl, M.D., Susan O’Brien, M.D., Farhad Ravandi-Kashani, M.D., Srdan Verstovsek, M.D., Ph.D., Guillermo Garcia-Manero, M.D., Jan Davisson, BS, ADN, Francis Giles, M.D., Jianqin Shan, Ph.D., Jean-Pierre Issa, M.D.
Journal: Blood
Blood (2006) 108 (11): 2652.
https://doi.org/10.1182/blood.V108.11.2652.2652
Published: 2006
Journal Articles

Survival Advantage for Patients (pts) with Chronic Myeloid Leukemia (CML) in Accelerated Phase (AP) Treated with Imatinib.

Jorge Cortes, M.D., Moshe Talpaz, M.D., Susan O’Brien, M.D., Guillermo Garcia-Manero, M.D., Farhad Ravandi-Kashami, M.D., Francis Giles, M.D., Stefan Faderl, M.D., William Wierda, M.D., Jianqin Shan, Ph.D., Mary Beth Rios, R.N., Hagop Kantarjian, M.D.
Journal: Blood
Blood (2004) 104 (11): 1006.
https://doi.org/10.1182/blood.V104.11.1006.1006
Published: 2004